The UNION chemistry platform has broad applicability across a versatile number of therapeutic areas. Due to the dual and novel modes of action, the UNION compounds lends themselves well to a broad range of diseases. As information about the complex and important interactions of the microbiome and the immune system is accumulating the potential therapeutic strategies enabled by UNION's chemistry platform is expanding.

UNION has established a pipeline comprising both known and novel molecules that have been discovered through medicinal chemistry. The current focus of UNION is primarily on inflammatory skin diseases, but opportunities beyond are many. Accordingly, UNION has entered into collaboration with some of the world’s leading academic groups to elucidate the vast potential of the chemical class in diverse disease areas.

We welcome collaboration with academia, biotech and pharma companies to further exploit the opportunities of the chemical class.